News

Neoasia Vietnam proudly marked the official launch of Botulinum Toxin A in Hanoi on March 20 at the Neoasia Vietnam Scientific Symposium (NVSS). 

On 2 March 2026, Neoasia Philippines hosted the Gala Awards 2026 at Grand Hyatt Manila, welcoming over 200 esteemed doctors, partners, and industry leaders from across the Philippines for an evening of celebration, innovation and partnership.

Neoasia recently hosted Riang Ria Bersama Neoasia, a Raya appreciation dinner held on 7 April 2026 at De.Wan 1958 by Chef Wan, The LINC KL.

Neoasia was honored to host Clinical Updates 2026 on 11 March, bringing together aesthetic physicians for a half-day scientific symposium featuring breakthrough technologies in body contouring, skin remodeling, and needle-free precision. It was a morning of focused learning, clinical insights, and professional exchange.

On 12 March 2026, Neoasia successfully hosted the Next Frontier Skin Science event at Sheraton Petaling Jaya, bringing together beauty professionals and valued business partners for an evening of learning, innovation, and collaboration.

Neoasia commenced the year with its Commercial Meeting 2026, held at Novotel Singapore on Stevens, bringing together 50 regional managers from across seven markets. The annual meeting served as a key platform to align commercial priorities, strengthen cross-market collaboration, and set the strategic direction for the year ahead.

On 10 February 10 2026, Neoasia Philippines successfully hosted the Neoasia Breakfast Symposium 2026, welcoming over 80 doctors, aesthetic physicians, cosmetic surgeons, and dermatologists for a morning dedicated to scientific learning and clinical excellence.

Neoasia proudly launches RevaleneLabs Paris in Singapore and Malaysia, introducing a new innovative pathway to combat hyperpigmentation with its patented Dendrix® technology.

Neoasia proudly launches RevaleneLabs in Singapore and Malaysia, introducing a new innovative pathway to combat hyperpigmentation with its patented Dendrix® technology.

Neoasia proudly hosted the 360 Obesity Summit, an insightful event dedicated to advancing holistic solutions for obesity management through innovation and collaboration. This summit marked a significant partnership between Neoasia and Novo Nordisk, reinforcing a shared commitment to improving patient outcomes in the Asia-Pacific region.